Case Report
Year: 2023 | Month: May | Volume: 10 | Issue: 5 | Pages: 202-205
DOI: https://doi.org/10.52403/ijrr.20230523
A Case Report of Phenytoin-Induced Stevens-Johnson Syndrome
K. Syedraja1, U. Karthikeyan2, Dr. S. Tamilselvan3
1Pharm. D Internship, Department of Pharmacy Practice, E.G.S. Pillay College of Pharmacy, Nagapattinam, Tamilnadu, India
2Pharm. D Internship, Department of Pharmacy Practice, E.G.S. Pillay College of Pharmacy, Nagapattinam, Tamilnadu, India
3MBBS, MD (General medicine) Department of General Medicine, Government Medical College and Hospital, Nagapattinam, Tamilnadu, India
Corresponding Author: Dr. S. Tamilselvan
ABSTRACT
Stevens-Johnson syndrome and Toxic epidermal necrosis are acute, self-limited diseases, rare but life-threatening adverse drug reactions. Anti-epileptic drug-induced Steven-Johnson syndrome is a severe cutaneous adverse reaction, among anti-epileptic drugs carbamazepine and phenytoin are the major culprit. We report here a case of Steven-Johnson syndrome due to phenytoin. A 22-year-old female reported the chief complaint of fever and multiple rashes all over the body with skin peeling, gradual onset, and progressive in nature. The reaction was evoked after intake of T. Phenytoin for 1 ½ months. She started heavy skin eruption all over the body for 15 days. She was treated with corticosteroids, anti-microbial, and anti-fungal agents. Healthcare providers must carefully regard the adverse effect of the drug, especially the one that is Steven-Johnson syndrome which is a potentially fatal condition. The most commonly prescribed drug regimen should also be used and continuously monitored to prevent adverse drug reactions.
Keywords: Steven-Johnson syndrome, Adverse drug reaction, Phenytoin, Skin eruption
[PDF Full Text]